{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:46:15Z","timestamp":1793083575560,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,2,12]],"date-time":"2004-02-12T00:00:00Z","timestamp":1076544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,2,12]],"date-time":"2004-02-12T00:00:00Z","timestamp":1076544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,4,1]]},"DOI":"10.1038\/sj.leu.2403302","type":"journal-article","created":{"date-parts":[[2004,2,12]],"date-time":"2004-02-12T06:03:04Z","timestamp":1076565784000},"page":"676-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":771,"title":["Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"18","author":[{"given":"C","family":"Imai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Andreansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I C","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-H","family":"Pui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T L","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,2,12]]},"reference":[{"key":"BF2403302_CR1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/sj.leu.2402872","volume":"17","author":"H Gadner","year":"2003","unstructured":"Gadner H, Haas OA, Masera G, Pui CH, Schrappe M . \u2018Ponte di Legno\u2019 Working Group \u2013 report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April\u20131 May 2002. Leukemia 2003; 17: 798\u2013803.","journal-title":"Leukemia"},{"key":"BF2403302_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00001622-200101000-00004","volume":"13","author":"A Verma","year":"2001","unstructured":"Verma A, Stock W . Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach. Curr Opin Oncol 2001; 13: 14\u201320.","journal-title":"Curr Opin Oncol"},{"key":"BF2403302_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","volume":"2","author":"CH Pui","year":"2001","unstructured":"Pui CH, Campana D, Evans WE . Childhood acute lymphoblastic leukemia \u2013 current status and future perspectives. Lancet Oncol 2001; 2: 597\u2013607.","journal-title":"Lancet Oncol"},{"key":"BF2403302_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0889-8588(18)30486-6","volume":"4","author":"R Champlin","year":"1990","unstructured":"Champlin R . T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation. Hematol Oncol Clin North Am 1990; 4: 687\u2013698.","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF2403302_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev.med.50.1.369","volume":"50","author":"DL Porter","year":"1999","unstructured":"Porter DL, Antin JH . The graft-versus-leukemia effects of allogeneic cell therapy. Annu Rev Med 1999; 50: 369\u2013386.","journal-title":"Annu Rev Med"},{"key":"BF2403302_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/35077251","volume":"411","author":"FR Appelbaum","year":"2001","unstructured":"Appelbaum FR . Haematopoietic cell transplantation as immunotherapy. Nature 2001; 411: 385\u2013389.","journal-title":"Nature"},{"key":"BF2403302_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1056\/NEJM199401133300204","volume":"330","author":"DL Porter","year":"1994","unstructured":"Porter DL, Roth MS, McGarigle C, Ferrara JL, Antin JH . Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 1994; 330: 100\u2013106.","journal-title":"N Engl J Med"},{"key":"BF2403302_CR8","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995; 86: 2041\u20132050.","journal-title":"Blood"},{"key":"BF2403302_CR9","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195","volume":"87","author":"S Slavin","year":"1996","unstructured":"Slavin S, Naparstek E, Nagler A, Ackerstein A, Samuel S, Kapelushnik J et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195\u20132204.","journal-title":"Blood"},{"key":"BF2403302_CR10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins Jr","year":"1997","unstructured":"Collins Jr RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433\u2013444.","journal-title":"J Clin Oncol"},{"key":"BF2403302_CR11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/sj.bmt.1701496","volume":"22","author":"LF Verdonck","year":"1998","unstructured":"Verdonck LF, Petersen EJ, Lokhorst HM, Nieuwenhuis HK, Dekker AW, Tilanus MG et al. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells. Bone Marrow Transplant 1998; 22: 1057\u20131063.","journal-title":"Bone Marrow Transplant"},{"key":"BF2403302_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.bmt.1702555","volume":"26","author":"RH Collins Jr","year":"2000","unstructured":"Collins Jr RH, Goldstein S, Giralt S, Levine J, Porter D, Drobyski W et al. Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant 2000; 26: 511\u2013516.","journal-title":"Bone Marrow Transplant"},{"key":"BF2403302_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/tmrv.2001.19949","volume":"15","author":"TL Geiger","year":"2001","unstructured":"Geiger TL, Jyothi MD . Development and application of receptor-modified T lymphocytes for adoptive immunotherapy. Transfus Med Rev 2001; 15: 21\u201334.","journal-title":"Transfus Med Rev"},{"key":"BF2403302_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nri841","volume":"2","author":"TN Schumacher","year":"2002","unstructured":"Schumacher TN . T-cell-receptor gene therapy. Nat Rev Immunol 2002; 2: 512\u2013519.","journal-title":"Nat Rev Immunol"},{"key":"BF2403302_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrc971","volume":"3","author":"M Sadelain","year":"2003","unstructured":"Sadelain M, Riviere I, Brentjens R . Targeting tumours with genetically enhanced T lymphocytes. Nat Rev Cancer 2003; 3: 35\u201345.","journal-title":"Nat Rev Cancer"},{"key":"BF2403302_CR16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4049\/jimmunol.131.1.244","volume":"131","author":"LM Nadler","year":"1983","unstructured":"Nadler LM, Anderson KC, Marti G, Bates M, Park E, Daley JF et al. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 1983; 131: 244\u2013250.","journal-title":"J Immunol"},{"key":"BF2403302_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0022-1759(00)00228-3","volume":"243","author":"D Campana","year":"2000","unstructured":"Campana D, Behm FG . Immunophenotyping of leukemia. J Immunol Methods 2000; 243: 59\u201375.","journal-title":"J Immunol Methods"},{"key":"BF2403302_CR18","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1182\/blood-2002-07-1989","volume":"101","author":"LJ Cooper","year":"2003","unstructured":"Cooper LJ, Topp MS, Serrano LM, Gonzalez S, Chang WC, Naranjo A et al. T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect. Blood 2003; 101: 1637\u20131644.","journal-title":"Blood"},{"key":"BF2403302_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm827","volume":"9","author":"RJ Brentjens","year":"2003","unstructured":"Brentjens RJ, Latouche JB, Santos E, Marti F, Gong MC, Lyddane C et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat Med 2003; 9: 279\u2013286.","journal-title":"Nat Med"},{"key":"BF2403302_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/00001622-199811000-00010","volume":"10","author":"DN Liebowitz","year":"1998","unstructured":"Liebowitz DN, Lee KP, June CH . Costimulatory approaches to adoptive immunotherapy. Curr Opin Oncol 1998; 10: 533\u2013541.","journal-title":"Curr Opin Oncol"},{"key":"BF2403302_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev.iy.05.040187.002443","volume":"5","author":"JP Allison","year":"1987","unstructured":"Allison JP, Lanier LL . Structure, function, and serology of the T-cell antigen receptor complex. Annu Rev Immunol 1987; 5: 503\u2013540.","journal-title":"Annu Rev Immunol"},{"key":"BF2403302_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.19.1.225","volume":"19","author":"B Salomon","year":"2001","unstructured":"Salomon B, Bluestone JA . Complexities of CD28\/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225\u2013252.","journal-title":"Annu Rev Immunol"},{"key":"BF2403302_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.V88.1.41.41","volume":"88","author":"AA Cardoso","year":"1996","unstructured":"Cardoso AA, Schultze JL, Boussiotis VA, Freeman GJ, Seamon MJ, Laszlo S et al. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood 1996; 88: 41\u201348.","journal-title":"Blood"},{"key":"BF2403302_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<881::AID-IMMU881>3.0.CO;2-0","volume":"28","author":"YJ Kim","year":"1998","unstructured":"Kim YJ, Kim SH, Mantel P, Kwon BS . Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses. Eur J Immunol 1998; 28: 881\u2013890.","journal-title":"Eur J Immunol"},{"key":"BF2403302_CR25","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.158.6.2600","volume":"158","author":"JC Hurtado","year":"1997","unstructured":"Hurtado JC, Kim YJ, Kwon BS . Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J Immunol 1997; 158: 2600\u20132609.","journal-title":"J Immunol"},{"key":"BF2403302_CR26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4049\/jimmunol.158.2.551","volume":"158","author":"MA DeBenedette","year":"1997","unstructured":"DeBenedette MA, Shahinian A, Mak TW, Watts TH . Costimulation of CD28\u2212 T lymphocytes by 4-1BB ligand. J Immunol 1997; 158: 551\u2013559.","journal-title":"J Immunol"},{"key":"BF2403302_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/immu.200310020","volume":"33","author":"J Bukczynski","year":"2003","unstructured":"Bukczynski J, Wen T, Watts TH . Costimulation of human CD28\u2212 T cells by 4-1BB ligand. Eur J Immunol 2003; 33: 446\u2013454.","journal-title":"Eur J Immunol"},{"key":"BF2403302_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1084\/jem.186.1.47","volume":"186","author":"WW Shuford","year":"1997","unstructured":"Shuford WW, Klussman K, Tritchler DD, Loo DT, Chalupny J, Siadak AW et al. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med 1997; 186: 47\u201355.","journal-title":"J Exp Med"},{"key":"BF2403302_CR29","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.162.9.5037","volume":"162","author":"C Takahashi","year":"1999","unstructured":"Takahashi C, Mittler RS, Vella AT . Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol 1999; 162: 5037\u20135040.","journal-title":"J Immunol"},{"key":"BF2403302_CR30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/sj.gt.3301687","volume":"9","author":"O Martinet","year":"2002","unstructured":"Martinet O, Divino CM, Zang Y, Gan Y, Mandeli J, Thung S et al. T cell activation with systemic agonistic antibody vs local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer. Gene Ther 2002; 9: 786\u2013792.","journal-title":"Gene Ther"},{"key":"BF2403302_CR31","first-page":"3459","volume":"62","author":"KF May Jr","year":"2002","unstructured":"May Jr KF, Chen L, Zheng P, Liu Y . Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells. Cancer Res 2002; 62: 3459\u20133465.","journal-title":"Cancer Res"},{"key":"BF2403302_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nm0697-682","volume":"3","author":"I Melero","year":"1997","unstructured":"Melero I, Shuford WW, Newby SA, Aruffo A, Ledbetter JA, Hellstrom KE et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med 1997; 3: 682\u2013685.","journal-title":"Nat Med"},{"key":"BF2403302_CR33","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1116::AID-IMMU1116>3.0.CO;2-A","volume":"28","author":"I Melero","year":"1998","unstructured":"Melero I, Bach N, Hellstrom KE, Aruffo A, Mittler RS, Chen L . Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway. Eur J Immunol 1998; 28: 1116\u20131121.","journal-title":"Eur J Immunol"},{"key":"BF2403302_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nm0402-343","volume":"8","author":"Z Ye","year":"2002","unstructured":"Ye Z, Hellstrom I, Hayden-Ledbetter M, Dahlin A, Ledbetter JA, Hellstrom KE . Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nat Med 2002; 8: 343\u2013348.","journal-title":"Nat Med"},{"key":"BF2403302_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1046\/j.1365-2567.2000.t01-1-00138.x","volume":"101","author":"S Mogi","year":"2000","unstructured":"Mogi S, Sakurai J, Kohsaka T, Enomoto S, Yagita H, Okumura K et al. Tumour rejection by gene transfer of 4-1BB ligand into a CD80(+) murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells. Immunology 2000; 101: 541\u2013547.","journal-title":"Immunology"},{"key":"BF2403302_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00262-002-0334-y","volume":"52","author":"H Yoshida","year":"2003","unstructured":"Yoshida H, Katayose Y, Unno M, Suzuki M, Kodama H, Takemura S et al. A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity. Cancer Immunol Immunother 2003; 52: 97\u2013106.","journal-title":"Cancer Immunol Immunother"},{"key":"BF2403302_CR37","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1182\/blood.V83.7.1731.1731","volume":"83","author":"A Manabe","year":"1994","unstructured":"Manabe A, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Pui CH et al. Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood 1994; 83: 1731\u20131737.","journal-title":"Blood"},{"key":"BF2403302_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V65.1.21.21","volume":"65","author":"RC Stong","year":"1985","unstructured":"Stong RC, Korsmeyer SJ, Parkin JL, Arthur DC, Kersey JH . Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics. Blood 1985; 65: 21\u201331.","journal-title":"Blood"},{"key":"BF2403302_CR39","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.2910190505","volume":"19","author":"U Schneider","year":"1977","unstructured":"Schneider U, Schwenk HU, Bornkamm G . Characterization of EBV-genome negative \u2018null\u2019 and \u2018T\u2019 cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 1977; 19: 621\u2013626.","journal-title":"Int J Cancer"},{"key":"BF2403302_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jcp.1040980203","volume":"98","author":"JM Harmon","year":"1979","unstructured":"Harmon JM, Norman MR, Fowlkes BJ, Thompson EB . Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line. J Cell Physiol 1979; 98: 267\u2013278.","journal-title":"J Cell Physiol"},{"key":"BF2403302_CR41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1126\/science.306682","volume":"200","author":"HP Koeffler","year":"1978","unstructured":"Koeffler HP, Golde DW . Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 1978; 200: 1153\u20131154.","journal-title":"Science"},{"key":"BF2403302_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ijc.2910170504","volume":"17","author":"C Sundstrom","year":"1976","unstructured":"Sundstrom C, Nilsson K . Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 565\u2013577.","journal-title":"Int J Cancer"},{"key":"BF2403302_CR43","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0161-5890(97)00144-2","volume":"34","author":"IC Nicholson","year":"1997","unstructured":"Nicholson IC, Lenton KA, Little DJ, Decorso T, Lee FT, Scott AM et al. Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma. Mol Immunol 1997; 34: 1157\u20131165.","journal-title":"Mol Immunol"},{"key":"BF2403302_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0378-1119(96)00674-9","volume":"186","author":"AN Warrens","year":"1997","unstructured":"Warrens AN, Jones MD, Lechler RI . Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene 1997; 186: 29\u201335.","journal-title":"Gene"},{"key":"BF2403302_CR45","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/blood.V89.10.3735.3735_3735_3744","volume":"89","author":"H Nishigaki","year":"1997","unstructured":"Nishigaki H, Ito C, Manabe A, Kumagai M, Coustan-Smith E, Yanishevski Y et al. Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia. Blood 1997; 89: 3735\u20133744.","journal-title":"Blood"},{"key":"BF2403302_CR46","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/sj.leu.2402523","volume":"16","author":"T Suzuki","year":"2002","unstructured":"Suzuki T, Coustan-Smith E, Mihara K, Campana D . Signals mediated by FcgammaRIIA suppress the growth of B-lineage acute lymphoblastic leukemia cells. Leukemia 2002; 16: 1276\u20131284.","journal-title":"Leukemia"},{"key":"BF2403302_CR47","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/sj.leu.2402510","volume":"16","author":"C Ito","year":"2002","unstructured":"Ito C, Tecchio C, Coustan-Smith E, Suzuki T, Behm FG, Raimondi SC et al. The antifungal antibiotic clotrimazole alters calcium homeostasis of leukemic lymphoblasts and induces apoptosis. Leukemia 2002; 16: 1344\u20131352.","journal-title":"Leukemia"},{"key":"BF2403302_CR48","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/j.1365-2141.2003.04217.x","volume":"120","author":"K Mihara","year":"2003","unstructured":"Mihara K, Imai C, Coustan-Smith E, Dome JS, Dominici M, Vanin E et al. Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol 2003; 120: 846\u2013849.","journal-title":"Br J Haematol"},{"key":"BF2403302_CR49","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood.V79.9.2370.2370","volume":"79","author":"A Manabe","year":"1992","unstructured":"Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D . Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 2370\u20132377.","journal-title":"Blood"},{"key":"BF2403302_CR50","first-page":"482","volume":"7","author":"D Campana","year":"1993","unstructured":"Campana D, Manabe A, Evans WE . Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Leukemia 1993; 7: 482\u2013488.","journal-title":"Leukemia"},{"key":"BF2403302_CR51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1182\/blood.V93.1.315","volume":"93","author":"C Ito","year":"1999","unstructured":"Ito C, Kumagai M, Manabe A, Coustan-Smith E, Raimondi SC, Behm FG et al. Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis. Blood 1999; 93: 315\u2013320.","journal-title":"Blood"},{"key":"BF2403302_CR52","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1182\/blood.V97.3.752","volume":"97","author":"K Srivannaboon","year":"2001","unstructured":"Srivannaboon K, Shanafelt AB, Todisco E, Forte CP, Behm FG, Raimondi SC et al. Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells. Blood 2001; 97: 752\u2013758.","journal-title":"Blood"},{"key":"BF2403302_CR53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","volume":"30","author":"A Bartholomew","year":"2002","unstructured":"Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42\u201348.","journal-title":"Exp Hematol"},{"key":"BF2403302_CR54","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","volume":"101","author":"M Krampera","year":"2003","unstructured":"Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722\u20133729.","journal-title":"Blood"},{"key":"BF2403302_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","volume":"57","author":"K Le Blanc","year":"2003","unstructured":"Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O . Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11\u201320.","journal-title":"Scand J Immunol"},{"key":"BF2403302_CR56","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1084\/jem.183.2.639","volume":"183","author":"Y Li","year":"1996","unstructured":"Li Y, Hellstrom KE, Newby SA, Chen L . Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors. J Exp Med 1996; 183: 639\u2013644.","journal-title":"J Exp Med"},{"key":"BF2403302_CR57","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 1038\u20131044.","journal-title":"N Engl J Med"},{"key":"BF2403302_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","volume":"345","author":"CM Rooney","year":"1995","unstructured":"Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA et al. Use of gene-modified virus-specific T lymphocytes to control Epstein\u2013Barr-virus-related lymphoproliferation. Lancet 1995; 345: 9\u201313.","journal-title":"Lancet"},{"key":"BF2403302_CR59","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1073\/pnas.95.7.3655","volume":"95","author":"RA MacCorkle","year":"1998","unstructured":"MacCorkle RA, Freeman KW, Spencer DM . Synthetic activation of caspases: artificial death switches. Proc Natl Acad Sci USA 1998; 95: 3655\u20133660.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403302_CR60","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1182\/blood-2002-08-2351","volume":"101","author":"S Marktel","year":"2003","unstructured":"Marktel S, Magnani Z, Ciceri F, Cazzaniga S, Riddell SR, Traversari C et al. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood 2003; 101: 1290\u20131298.","journal-title":"Blood"},{"key":"BF2403302_CR61","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/10430340050015798","volume":"11","author":"M Introna","year":"2000","unstructured":"Introna M, Barbui AM, Bambacioni F, Casati C, Gaipa G, Borleri G et al. Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-CD20 antibodies. Hum Gene Ther 2000; 11: 611\u2013620.","journal-title":"Hum Gene Ther"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403302","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T19:47:02Z","timestamp":1682624822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,12]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4,1]]}},"alternative-id":["BF2403302"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403302","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,12]]},"assertion":[{"value":"31 December 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}